This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Behavioural Health Remove Regulation Remove Trials Related Topics
Pharma Companies Pharmacy Doctors Life Science Development Research Clinical Trials Medicine Marketing Business Development More Related Topics >
article thumbnail

Cognoa preps FDA filing for digital autism diagnostic

pharmaphorum

SEPTEMBER 24, 2020

An artificial intelligence-powered diagnostic for autism spectrum disorder (ASD), developed by Cognoa, has met all its objectives in a pivotal trial and will be filed for approval with the FDA. Cognoa has revealed however that the trial suggests the app is highly accurate across males and females as well as ethnic and racial backgrounds.

Behavioural Health 111
Behavioural Health Doctors Doctor Development 111
article thumbnail

What we’re expecting in 2021, and beyond…

pharmaphorum

JANUARY 26, 2021

From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are expected to shake up digital health this year. Clinical trials get more and more digitalised. Aging in place’ becomes more commonplace.

Clinical Trials 136
Clinical Trials Clinical Trials Sales Life Science 136
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024